相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial
Mihai Gheorghiade et al.
HEART FAILURE REVIEWS (2012)
Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics
Peter Kolkhof et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes
M. Albaghdadi et al.
EUROPEAN HEART JOURNAL (2011)
CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure
John J. V. McMurray
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Aldosterone Blockers (Mineralocorticoid Receptor Antagonism) and Potassium-Sparing Diuretics
Murray Epstein et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
Hari K. Parthasarathy et al.
JOURNAL OF HYPERTENSION (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome
Wojciech Kosmala et al.
JACC-CARDIOVASCULAR IMAGING (2011)
EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot)
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
Jerome Fagart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Stereochemical Requirements for the Mineralocorticoid Receptor Antagonist Activity of Dihydropyridines
Graciela B. Arhancet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Lisa M. Einhorn et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Mineralocorticoid Receptor Blockers and Chronic Kidney Disease
Gaurav Jain et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Use of Aldosterone Antagonists in Heart Failure
Nancy M. Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Change in proteinuria after adding aldosterone Blockers to ACE inhibitors or angiotensin receptor Blockers in CKD: A systematic review
Andrew S. Bomback et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Heart Failure Care in the Outpatient Cardiology Practice Setting Findings From IMPROVE HF
Gregg C. Fonarow et al.
CIRCULATION-HEART FAILURE (2008)
A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity
Jessica D. Dietz et al.
HYPERTENSION (2008)
Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline
John W. Funder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
S. Bianchi et al.
KIDNEY INTERNATIONAL (2006)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
MH Weinberger et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Mechanisms of disease - Aldosterone in congestive heart failure
KT Weber
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
